Therefore, only the specific phenotypes may guide the clinician in choosing the most accurate genetic test, but the successive testing of genes related to the well-known hereditary tumor syndromes (MEN2, VHL, NF1 and paraganglioma syndromes) would lead to a long and burdensome process. Here, NF1 is linked to hereditary neoplastic syndrome.